PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY

Similar documents
Children who are neutropenic and unwell, even if normothermic, should be assumed to have infection and be treated appropriately.

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

Title Management of Fever and Neutropenia (Neutropenic Sepsis) in Paediatric Oncology Patients presenting to NDDH Guidelines. Author s job title

Protocol for the Management of Neutropenic Sepsis in Adult Patients P

Antimicrobial Management of Febrile Neutropenic Sepsis

Scottish Childrens Cancer MSN CYPC Febrile Neutropenia Guideline December 2013, Version 1

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway

Neutropenic Sepsis Guideline

Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease

PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS

BREAK 11:10-11:

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

NEUTROPENIC SEPSIS IN ADULT PATIENTS. Consultant Clinical Oncologist CLINICAL GUIDELINE

High Dose Cytarabine plus high dose Methotrexate for CNS Lymphoma

INFLECTRA Infliximab Infusion 1,2 & 3

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Lung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

Lung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology

SOUTH THAMES CHILDREN S CANCER NETWORK GROUP. REFERRAL PROTOCOLS AND DIAGNOSIS AND STAGING PROTOCOLS October 2014

GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

FOLFIRINOX (Irinotecan, Oxaliplatin & infusional Fluorouracil) Cumbria, Northumberland, Tyne & Wear Area Team

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?

NECN CHEMOTHERAPY HANDBOOK PROTOCOL

Trust Guideline for the Management of: Condition or Procedure in Adults and / or Children

R-GDP: Rituximab, Gemcitabine, Dexamethasone &Cisplatin

Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy.

The Management of Acute Chest Syndrome in Children with Sickle Cell Disease

Charlson Comorbidities (please TICK all that apply)

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

. AREAS OF RESPONSIBILITY FOR SHARED CARE

Right Iliac Fossa Pain

Protocol for Management of Neutropenic Sepsis in Adult Patients within the First 24 hours of Presentation

R-BAC-500 (Rituximab, Bendamustine, Cytarabine) for Mantle Cell Lymphoma

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital

GUIDELINE FOR THE MANAGEMENT OF MENINGOCOCCAL DISEASE

Fever in children aged less than 5 years

Pharmacy Prior Authorization

Management of common chemotherapy related side effects. Dr Lee-Ann Jones

Antibiotic Protocols for Paediatrics Steve Biko Academic Hospital

Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy

North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance)

Dilemmas in Septic Shock

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

A 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary

CASE SCENARIO EXERCISE

MAKING SENSE OF IT ALL AUGUST 17

(primary CNS lymphoma)

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Patient Treatment Date/time: Diagnosis: Treatment Regimen:

This is a controlled document and therefore must not be changed or photocopied L.80 - R-CHOP-21 / CHOP-21

Glossary of terms used in IEEM. Hong Kong College of Emergency Medicine March 2013

The Oxford AHSN Sepsis Pathway

Staging Sepsis for the Emergency Department: Physician

Rituximab (weekly) for Primary Cutaneous B cell Lymphoma

Wessex Paediatric Oncology Supportive Care Guidelines: Management of Febrile Neutropenia

Unwell returned traveller

PedsCases Podcast Scripts

AE Toxicity Grading for Transplant Patients

SEPSIS INFORMATION BOOKLET. A life-threatening condition triggered by infection

DMARDS MONITORING GUIDELINES SELKIRK MEDICAL PRACTICE

Have you ever managed patients who have experienced an adverse reaction to transfusion?

Fractured Neck of Femur Proforma Orthopaedic Unit. First name: Registration no: Date of birth: Age:

FOLFIRINOX (pancreas)

Haemodialysis central venous catheter-related sepsis management guideline Version 3. NAME M. Letheren Chair Clinical Effectiveness Advisory Group

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

PREOPERATIVE ANAEMIA PATHWAY

Cetuximab in Combination with Irinotecan based Chemotherapy for the 1 st, 2 nd and 3 rd treatment Metastatic of Colorectal Cancer

The changing face of

CASE-BASED SMALL GROUP DISCUSSION MHD II

StRs and CT doctors in haematology. September Folinic acid dose modified.

R-GDP: Rituximab, Gemcitabine, Dexamethasone &Cisplatin

Fludarabine + Cyclophosphamide + Rituximab (FCR) - FLAIR Study

Management of Nephrotic Syndrome

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Cisplatin and Gemcitabine Bladder Cancer: Full and split dose

SMILE (Etoposide, Ifosfamide, Methotrexate and Dexamethasone)

FEBRILE NEUTROPENIA CURRENT GUIDELINES FOR CHILDREN Alia Zaidi, MD. St. Jude International Outreach Program

Obinutuzumab+Bendamustine followed by Obinutuzumab Maintenance Burton in-patient Derby in-patient Burton day-case Derby day-case

DERBY-BURTON LOCAL CANCER NETWORK FILENAME SMILE.DOC CONTROLLED DOC NO: HCCPG B57 CSIS Regimen Name: SMILE. SMILE chemotherapy

9/15/2017. Joyce Turner RN Director of Clinical Program Development

TACO CASE STUDIES RTC JUNE Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner

Guidelines for the management of paediatric burns

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013

The immediate management of burns patients should be similar to management of trauma.

LOKUN! I got stomach ache!


A rash case Infection control management of measles

It s Not A Tumor! Oncologic Emergencies

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Sepsis in primary care. what is good care?

Transcription:

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic sepsis. Background: Children with cancer are particularly susceptible to life-threatening infections. Chemotherapy affects the body's normal defences against infection by causing marrow depression and in some cases disrupts mucous membranes in the gut & mouth. Central lines and bone marrow sites are a potential focus of infection. Definition: Neutropenic Sepsis is a Medical Emergency, which can be life threatening. Intravenous antibiotics MUST be given within one hour of arrival in the hospital or within one hour of the signs and symptoms developing if the patient is an in patient. Signs and symptoms of neutropenic sepsis Fever of 38.5 C on one occasion Fever of 38 C on two occasions 1 hour apart in patients with neutrophil count <0.75 x 10 9 /L Fever is usually the first (and may be the only) sign of neutropenic sepsis, but neutropenic sepsis can occur in the absence of fever, especially in patients on corticosteroids or following administration of paracetamol Other symptoms and signs include: Influenza-like symptoms Drowsiness or confusion Hypotension Tachycardia Vomiting Obvious focus of infection (e.g. mouth, chest, urine, diarrhoea) Children who are neutropenic and unwell, even if normothermic should be assumed to have infection and be treated appropriately. Management of Pyrexia/Infection For more detailed information please refer to the Shared Care Guidelines. Step 1: History Ask about pain around line site, cough, dyspnoea, abdominal pain, diarrhoea, fluid intake, line flushing. Onset of temperature within a few hours of having a line flushed may represent a line infection. Children receiving chemotherapy that induces mucositis are more likely to acquire Gram negative infections. 1

Step 2: Examination Check line entry & exit site & any recent bone marrow or lumbar puncture sites in addition to normal examination. Measure peripheral perfusion, blood pressure, respiratory rate, oxygen saturation if indicated, ongoing fluid losses & urinary output. Step 3: Determine Risk Group Low risk group ALL on maintenance treatment only Wilms Lymphomas on Euro-LB Rhabdomyosarcoma Low stage neuroblastoma Most brain tumour protocols Osteosarcoma Ewing s consolidation Hodgkin s Standard risk group ALL all phases of treatment except maintenance AML Intensive B-NHL protocols Anaplastic lymphomas Stage IV neuroblastoma BMT or PBSCT pre engraftment Ewing's Induction (VIDE chemotherapy) If patient has signs of severe sepsis (hypoxia, poor peripheral perfusion, hypotension, altered conscious state) he/she is not eligible to stay in low risk group and should be treated as for standard risk group. Step 4: Investigations Immediate investigations should include Blood cultures Cultures should be taken from each lumen of the central line appropriately labelled. Peripheral cultures are not routinely done, but there may be specific instances where this is appropriate. If clinically concerned about anaerobic infection, eg with severe mucositis remember to take anaerobic blood cultures. FBC, U&Es, CRP These can be taken from the central line immediately on arrival to hospital, by a trained member of Nursing Staff or Doctor. Antibiotic therapy can then be instigated. Other investigations should include MSU Bacteriology and mycology especially in young children Swab From skin lesions/central line sites if applicable (look for areas of redness and tenderness: pus not present when neutropenic) Investigations to consider if clinically indicated Stool MC&S, mycology and virology if diarrhoea CXR LP NPA All culture specimens should ideally be done before antibiotics are given but do not delay unnecessarily in giving antibiotics (for example in collecting a urine sample). 2

Step 5: Treatment Low Risk Group (ALL maintenance, most non-relapsed solid tumours except B-NHL, anaplastic lymphoma, intensive stage IVs) 3

Standard Risk Group (ALL except on maintenance, AML, PBSCT, B-NHL, anaplastic lymphoma, intensive stage IVs) If Penicillin allergy consider either Ceftazidime and Gentamicin or Ciprofloxacin and Teicoplanin. Beware 10% crossover allergy possible between penicillins and cephalosporins. 4

Patient Clerking- Nursing Consultant Date and time of admission: Nursing observations: (please complete each area) Temperature: C O 2 saturation: % on air Pulse rate: /min Respiratory rate: /min BP: CALL DOCTOR Doctor MUST be aware that an URGENT response is required Time doctor called: Initial Nursing Assessment 5

Patient Clerking- Nursing Intravenous Access: If patient has a central venous catheter a trained member of staff, if available, should take bloods from the line as indicated below. Available: Yes No Bloods taken: Blood Cultures from each lumen Yes No FBC Yes No U&E/LFT Yes No CRP Yes No G&S Yes No N/A Coagulation Screen Yes No N/A Other Investigations: MSU Line swab Stool culture (if appropriate) If patient not seen by Doctor within 30 minutes of admission, please contact on call Registrar/ Consultant. 6

Time of medical assessment: History: (please complete each area) Presenting symptoms: Underlying condition: Stage of Treatment and Recent Treatment: Medications: Allergies: (including concerns regarding use of Gentamicin or Cisplatin) Previous reaction to Blood products: Yes No if so, which: Most recent blood count: Date: Result: 7

Clinical Examination: (please complete each area) Conscious Level: Mouth: Clean Mucositis Ulcerated Candida Line Site: Clean Inflamed Purulent N/A CVS: Blood Pressure: Pulse: CRT: Heart Sounds: Respiratory: Respiratory rate: Oxygen Saturations: Abdominal: Perineum: Clean Inflamed Ulcerated Other: 8

Investigations: Note: Bloods may have already been taken by nursing staff. FBC Yes No U&E/LFT Yes No CRP Yes No G&S Yes No N/A Coagulation Screen Yes No N/A Blood Cultures Central Peripheral (if no central access) MSU Line swab Stool culture (if appropriate) CXR (if appropriate) 9

Management: Details of Emergency Resuscitation if required: Antibiotic Therapy (please tick chosen therapy): Low Risk Group: Tazocin./kg (Piperacillin and Tazobactam) Penicillin allergy Yes No Standard Risk Group: Tazocin /kg and Gentamicin /kg If Penicillin allergy consider either Ceftazidime/Gentamicin or Ciprofloxacin /Teicoplanin instead of Tazocin. Beware 10% crossover allergy between Penicillins and Cephalosporins. Be aware Gentamicin is contraindicated if patient is about to receive Cisplatin, patient has had Cisplatin in the last 6 weeks, or during high dose Methotrexate treatment & rescue. Caution in renal impairment or if significant risk there of e.g. tumour lysis. Continue Cotrimoxazole prophylaxis if taking. Please record time of antibiotics given: Antibiotic 1: Antibiotic 2 (if applicable) Time first dose administered: 10

Management: Additional Therapy required: Analgesia: Yes No Maintenance fluids: Yes No Blood Products: Yes No Nutrition: Yes No Please inform Middle Grade/ Consultant of admission at appropriate time. Date and Time informed: Senior Review: 11

Results Date Hb Wbc Plt Neutrophils Na K Urea Creatinine CRP Albumin Protein ALP ALT Bilirubin Calcium Phosphate Magnesium Microbiological Results Date sent Culture site Result Organism, Sensitivites and Date Reported 12

Discharge Check List: Standard Discharge letter with TTO s completed: Yes No Piam Brown Discharge form completed and faxed: Yes No Date of next blood test arranged: Yes No Date of next Hospital appointment arranged: Yes No Community Nurses informed of discharge: Yes No Dr Staples aware of admission and discharge: Yes No 13